Related Experiment Videos
Ischemic brain damage: focus on lipids and lipid mediators
1Department of Neurobiology, University Hospital S-221, Lund, Sweden.
Advances in Experimental Medicine and Biology
|January 1, 1992
Summary
Ischemia triggers lipid breakdown, producing cytotoxic compounds and inflammatory mediators like platelet-activating factor (PAF) and eicosanoids. These lipid mediators, along with free radicals, contribute to cell damage and death in ischemic tissues.
Area of Science:
- Biochemistry
- Cellular Biology
- Pathophysiology
Background:
- Ischemia leads to phospholipid degradation, generating cytotoxic lipid breakdown products.
- These products are converted into various lipids that mediate cellular and intercellular reactions.
Purpose of the Study:
- To elucidate the role of lipid breakdown products and subsequent reactions in ischemia-induced cell damage.
- To understand the contribution of inflammatory mediators and free radicals to cell death in reperfused tissues.
Main Methods:
- Review of recent research on lipid metabolism during ischemia.
- Analysis of mechanisms involving platelet-activating factor (PAF) and arachidonic acid metabolites.
- Investigation of the role of free radicals and protein kinase C (PKC) in cellular injury.
Main Results:
- Ischemia causes phospholipid degradation and accumulation of cytotoxic lipid products.
- Platelet-activating factor (PAF) and arachidonic acid metabolites (eicosanoids) induce microvascular changes, jeopardizing cell survival.
- Free radicals, particularly after prolonged ischemia, contribute to cell damage alongside eicosanoids and PAF.
- Sustained protein kinase C (PKC) activation is implicated in delayed neuronal death after transient ischemia.
Conclusions:
- Lipolytic events are crucial for cell damage in ischemia and conditions of compromised cellular energy metabolism.
- Understanding these lipid-mediated pathways is vital for developing therapeutic strategies against ischemic injury.